Compounders Question FDAs Rationale and Evidence Pointing to Safety Concerns On October 27, 2023, APC urged FDA via letter addressed to Gail Bormel, Director of the FDA's Office of Compounding Quality and Compliance, for transparency regarding the recent inclusion of substances into Category 2
2 Individuals with TN often experience increased rates of psychiatric comorbidities, including depression, anxiety, and sleep disorders, compared with the general population
Why Its Different from Retinoids and Peels Retinoids and chemical peels work by speeding up cell turnover, which can be effective but also quite harsh on the skin
Gently swirl until dissolved (10-20 minutes)
Chelated forms like magnesium malate or glycinate are better absorbed
While Medicare provides coverage under specific conditions, the rules are stricter than many expect, and costs can vary significantly based on the type of coverage and medical necessity, making it essential to stay informed about eligibility and documentation requirements